Why a Full Catalogue Review Should Precede Any Shortlist
Updating a laboratory standard operating procedure (SOP) for research compounds is rarely a simple substitution exercise. Each material entering an in-vitro workflow needs a documented, traceable rationale: why it was selected, how it will be stored, which batch documentation applies, and how it fits the laboratory’s risk assessment. A shortlist assembled from memory, a single search, or a previous SOP may overlook alternatives, documentation gaps, or handling constraints. A structured review of the full UK catalogue should therefore come before any shortlist is finalised. All materials remain research-use-only and not for human or veterinary use.
A full catalogue review gives the SOP author context. It shows what categories exist, how listings are written, what documentation is available, and how storage and handling guidance is presented. For example, the all-products category brings together research peptides, laboratory accessories, and preparation tools. Visible catalogue examples include Tesamorelin 5mg, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg, BPC-157 10mg, MT-1 10mg, Bacteriostatic Water 10ml (also worded as 10ml Mixing Water), and a Storage Container. Seeing these items together helps the SOP author compare form, packaging, documentation, and storage requirements before narrowing the field.
A practical starting point is to review the current all-products page via Buy peptides uk and then open each candidate’s product page and batch CoA. The shop describes batch-level analytical verification supporting purity, identity, and contaminant screening, with CoAs linked to supported products. The homepage lists “CoAs Janoshik Analytical Reports”; the researcher should still check the CoA for the specific batch. Published figures such as “≥99% Verified Purity” and “3,000+ UK Orders” are the shop’s current wording and should be reconfirmed on the live site and against the batch CoA. The FAQs note that restocked products may carry the same Internal Test Reference (ITR) as earlier stock; an ITR links to sample testing reports but does not confirm separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours may vary and are not an indicator of identity, analytical quality, or manufacturing origin.
Building a Shortlisting Matrix from Catalogue Data
Once the full catalogue has been reviewed, convert browsing into a shortlisting matrix. Useful columns include material name, catalogue reference or strength, published form, storage requirements, documentation available, supplier terms, intended SOP application, and risk notes. This turns a list of interesting items into evidence that can be reviewed, approved, and version-controlled. For an in-vitro assay workflow, the matrix might include three candidate research peptides, preparation tools, and a storage container, each assessed against the SOP’s acceptance criteria. Record whether the material is supplied as a lyophilised powder, the label reference, and which CoA applies.
Documentation deserves particular attention. The FAQs state that every product includes a CoA for HPLC purity and identity, that compounds are manufactured by international partners using solid-phase peptide synthesis, and that products are subject to final verification and quality checks in the UK before release. The About page describes full-spectrum testing as purity, identity, heavy metals, and endotoxin evaluation of submitted samples. These are the shop’s stated positions, not independent audit results, so the SOP should require the researcher to verify the actual batch document. Vial labels use a reference format combining SKU code and expiry date, for example BPC10-03/27, linking to the corresponding CoA. Quote that reference when contacting the shop about documentation. Do not assume that a cap colour, a restock, or an ITR alone confirms a production lot or separate independent testing.
Storage and handling belong in the shortlisting matrix alongside the material name. The FAQ quick guide says to allow vials to reach room temperature before opening, work in a clean environment, and only remove the amount required for the experiment. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant, protected from moisture, heat, and light; avoid repeated freeze–thaw cycles. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. The shop’s free reconstitution calculator is for laboratory research use only and must not be used for human or veterinary dosing. The FAQs note that all peptides contain trace amounts of mannitol as an excipient, and that the shop does not supply blended peptides; buy peptides individually and combine them only within a controlled experimental design. These points belong in the SOP’s materials and handling section, alongside the reminder that materials are not for human or veterinary use.
Integrating Catalogue Review into SOP Revision and Supplier Checks
The catalogue review should be documented as part of the SOP revision itself. Version control, change rationale, risk assessment, training records, and approval signatures all benefit from a clear audit trail showing why a shortlist was chosen from the wider catalogue. A materials manager might attach the completed shortlisting matrix to the SOP change record, while the researcher confirms that each candidate’s batch CoA, storage conditions, and handling requirements align with the in-vitro workflow. Research Sciences is the current shop name; the FAQs state that Research Sciences is the parent company of Imperial Peptides UK, and that Imperial Peptides UK continues to operate as a brand. The purchaser remains responsible for lawful use, safe handling, storage, and disposal, and for compliance with relevant UK regulations including COSHH and laboratory safety standards.
Supplier checks should also be captured. Published terms state that orders are dispatched the next working day and shipped via Royal Mail Tracked 24, which usually delivers the following working day according to the Royal Mail estimate. Tracking is provided after dispatch, and delivery times are estimates that may vary in peak periods. The homepage “24hr UK Delivery” line is a marketing statement and should not be treated as a guaranteed next-day arrival. No returns are accepted once dispatched because of the specialist and perishable nature of the goods; refunds are only for damage, incorrect supply, or quality issues as set out in the Refunds & Returns Policy. Payments are described as Pay-By-Bank / Open Banking, powered with providers such as Wallid and regulated by the FCA; the shop says it does not accept card payments because research-use-only scientific materials fall into high-risk merchant categories. Reconfirm these terms at checkout before the SOP locks in a supplier pathway.
As a real-world example, a UK laboratory updating an SOP for in-vitro receptor signalling studies might begin with a full catalogue review, shortlist three candidate research peptides plus preparation tools, verify each batch CoA and storage requirement, and then check dispatch, payment, and documentation terms. The SOP would record the shortlisting rationale, the CoA references, the in-vitro handling limits, and the requirement that all materials remain not for human or veterinary use. Keeping the review cycle aligned with the live catalogue matters because listings, CoAs, and published terms can change. A final re-check before approval should confirm the current catalogue wording, the specific batch CoA, and any restock ITR caveat, and that confirmation should be recorded in the SOP change record.
